Eyedrop grows from second- to first-line Rx for glaucoma

July 3, 2006

Until now, Lumigan (bimatoprost ophthalmic solution) 0.03% was used as a second-line treatment for glaucoma. Now the Allergan once-daily prescription eyedrop has been approved for first-line treatment of elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension.

Eyedrop grows from second- to first-line Rx for glaucoma

Until now, Lumigan (bimatoprost ophthalmic solution) 0.03% was used as a second-line treatment for glaucoma. Now the Allergan once-daily prescription eyedrop has been approved for first-line treatment of elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

Related Content:

News